Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma.
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2009
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.